Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple SclerosisStephen L. Hauser, Jerry S. Wolinsky, Ludwig Kappos et al.|Neurology|2021Cited by 181
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trialsTobias Derfuß, Amit Bar‐Or, Ludwig Kappos et al.|Therapeutic Advances in Neurological Disorders|2024Cited by 23